These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 851495

  • 1. Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse.
    Reddy JK, Moody DE, Azarnoff DL, Tomarelli RM.
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):51-7. PubMed ID: 851495
    [Abstract] [Full Text] [Related]

  • 2. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK, Azarnoff DL, Sirtori CR.
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [Abstract] [Full Text] [Related]

  • 3. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
    Reddy JK, Krishnakantha TP.
    Science; 1975 Nov 21; 190(4216):787-9. PubMed ID: 1198095
    [Abstract] [Full Text] [Related]

  • 4. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS, Cattley RC, Conway JG, Popp JA.
    Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents.
    Moody DE, Reddy JK, Azarnoff DL.
    Biochem Pharmacol; 1984 Aug 15; 33(16):2591-7. PubMed ID: 6431985
    [Abstract] [Full Text] [Related]

  • 6. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE, Reddy JK.
    Am J Pathol; 1978 Feb 15; 90(2):435-46. PubMed ID: 623209
    [Abstract] [Full Text] [Related]

  • 7. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.
    Reddy JK, Rao MS, Azarnoff DL, Sell S.
    Cancer Res; 1979 Jan 15; 39(1):152-61. PubMed ID: 83907
    [No Abstract] [Full Text] [Related]

  • 8. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
    Lalwani ND, Reddy MK, Qureshi SA, Reddy JK.
    Carcinogenesis; 1981 Jan 15; 2(7):645-50. PubMed ID: 7273344
    [Abstract] [Full Text] [Related]

  • 9. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG.
    Chem Res Toxicol; 1997 Oct 15; 10(10):1198-204. PubMed ID: 9348444
    [Abstract] [Full Text] [Related]

  • 10. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC, Popp JA.
    Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380
    [Abstract] [Full Text] [Related]

  • 11. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
    Woods CG, Burns AM, Bradford BU, Ross PK, Kosyk O, Swenberg JA, Cunningham ML, Rusyn I.
    Toxicol Sci; 2007 Aug 15; 98(2):366-74. PubMed ID: 17483499
    [Abstract] [Full Text] [Related]

  • 12. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
    Reddy MK, Lalwani ND, Qureshi SA, Reddy JK.
    Hum Toxicol; 1982 Mar 15; 1(2):135-47. PubMed ID: 7173894
    [Abstract] [Full Text] [Related]

  • 13. Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (Wy-14,643)-induced carcinogenesis.
    Rao MS, Lalwani ND, Reddy JK.
    J Natl Cancer Inst; 1984 Oct 15; 73(4):983-90. PubMed ID: 6592391
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.
    Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, Thurman RG.
    Carcinogenesis; 1997 Apr 15; 18(4):669-74. PubMed ID: 9111198
    [Abstract] [Full Text] [Related]

  • 15. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK, Thurman RG.
    Toxicol Appl Pharmacol; 1996 Oct 15; 140(2):322-7. PubMed ID: 8887448
    [Abstract] [Full Text] [Related]

  • 16. Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat.
    Lazarow PB.
    Science; 1977 Aug 05; 197(4303):580-1. PubMed ID: 195342
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferation and lipid peroxidation in rat liver.
    Goel SK, Lalwani ND, Reddy JK.
    Cancer Res; 1986 Mar 05; 46(3):1324-30. PubMed ID: 3943099
    [Abstract] [Full Text] [Related]

  • 18. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo.
    Bojes HK, Thurman RG.
    Toxicol Appl Pharmacol; 1994 Jun 05; 126(2):233-9. PubMed ID: 8209376
    [Abstract] [Full Text] [Related]

  • 19. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK.
    Am J Pathol; 1974 Apr 05; 75(1):103-18. PubMed ID: 4825610
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.